Lung cancer screening in Australia: Progress or procrastination?: There is progress internationally with lung cancer screening but far slower headway in Australia

Medical Journal of Australia

Volumn 204, Issue 1, 2016, Pages 4-4.e1

  Brims, Fraser ^a   McWilliams, Annette ^b   Fong, Kwun ^c  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^b FIONA STANLEY HOSPITAL   (Australia)

^c THE PRINCE CHARLES HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AUSTRALIA; CANCER SCREENING; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; EARLY DIAGNOSIS; ECONOMIC EVALUATION; EDITORIAL; HEALTH CARE COST; HUMAN; LUNG CANCER; LUNG NODULE; MORTALITY; QUALITY ADJUSTED LIFE YEAR; SMOKING CESSATION; SMOKING CESSATION PROGRAM; TOBACCO; EARLY CANCER DIAGNOSIS; FORECASTING; LUNG NEOPLASMS; TRENDS;

AUSTRALIA; EARLY DETECTION OF CANCER; FORECASTING; HUMANS; LUNG NEOPLASMS;

EID: 84954518012     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mja15.01109     Document Type: Editorial

References (13)

1. Australian Bureau of Statistics. Statistics section. http://www.abs.gov.au/AUSSTATS/abs@.nsf/webpages/statistics?opendocument (accessed Sep 2015).
2. Peto R, Darby S, Deo H, et al. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ 2000; 321: 323329.
3. Field JK, Smith RA, Aberle DR, et al. International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 report. J Thorac Oncol 2012; 7: 10-19.
4. Tammemagi MC, Lam S. Screening for lung cancer using low dose computed tomography. BMJ 2014; 348: g2253.
5. Cressman S, Lam S, Peacock S, et al. Economic evidence for the use of risk-selection and risk-stratification for lung cancer screening programs. J Thorac Oncol 2015; 10 (Suppl 1): ORAL09.07.
6. Sharp L, Tilson L, Whyte S, et al. Cost-effectiveness of population-based screening for colorectal cancer: a comparison of guaiac-based faecal occult blood testing, faecal immunochemical testing and flexible sigmoidoscopy. Br J Cancer 2012; 106: 805-816.
7. Pharoah PD, Sewell B, Fitzsimmons D, et al. Cost effectiveness of the NHS breast screening programme: life table model. BMJ 2013; 346: f2618.
8. Cressman S, Lam S, Tammemagi MC, et al. Resource utilization and costs during the initial years of lung cancer screening with computed tomography in Canada. J Thorac Oncol 2014; 9: 1449-1458.
9. Standing Committee on Screening, Cancer Australia 2015. Position statement: lung cancer screening using low-dose computed tomography. Canberra: Cancer Australia, 2015. http://www.cancerscreening.gov.au/internet/screening/publishing.nsf/Content/EA40B7C67280E5C8CA257CEE00012DA1/$File/Position%20Statement-%20Lung%20Cancer%20Screening%20using%20Low-Dose%20Computed%20Tomography.pdf (accessed Sep 2015).
10. Marshall HM, Bowman RV, Ayres J, et al. Lung cancer screening feasibility in Australia. Eur Respir J 2015; 45: 1734-1737.
11. Brims FJ, Murray CP, de Klerk N, et al. Ultra-low-dose chest computer tomography screening of an asbestos-exposed population in Western Australia. Am J Respir Crit Care Med 2015; 191: 113-116.
12. Pastorino U, Boffi R, Machiano A, et al. Stopping smoking reduces mortality in low-dose computed tomography (LDCT) screening volunteers. J Thorac Oncol 2015; 10 (Suppl 2): PLEN04.07.
13. Tammemagi MC, Berg CD, Riley TL, et al. Impact of lung cancer screening results on smoking cessation. J Natl Cancer Inst 2014; 106: dju084.